Structure via PubChem · Public domain (PubChem)
milnacipran
Sign in to saveAlso known as (-)-milnacipran, Midalcipran, Milnacipranum, Savella
Milnacipran (trade names Ixel, Savella, Dalcipran, Toledomin) is a serotonin–norepinephrine reuptake inhibitor (SNRI) used in the clinical treatment of fibromyalgia, major depressive disorder, and neuropathic pain. In the US, it is solely approved for the treatment of fibromyalgia, even though it is also approved for the treatment of major depressive disorder (but not fibromyalgia) in other countries (e.g. France).
Chemical data
- Formula
- C15H22N2O
- Molecular weight
- 246.35 g/mol
- IUPAC name
- cis-(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide
- SMILES
- CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2
- InChIKey
- GJJFMKBJSRMPLA-HIFRSBDPSA-N
- XLogP
- 1.4
- Polar surface area
- 46.3 Ų
- H-bond donors
- 1
- H-bond acceptors
- 2
- Formal charge
- 0
via PubChem
Research
850 papers- Milnacipran for the Treatment of Fibromyalgia.Health psychology research · 2021
- Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant.Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists · 2018
- Milnacipran for neuropathic pain in adults.The Cochrane database of systematic reviews · 2015
- Milnacipran for pain in fibromyalgia in adults.The Cochrane database of systematic reviews · 2015
- Milnacipran. A review of its use in depression.Drugs · 1998
via PubMed
~8 min read
Encyclopedic overview
13 sectionsContents
- Medical uses
- Depression
- Fibromyalgia
- Social anxiety
- Contraindications
- Side effects
- Interactions
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- History
- References
- External links
Milnacipran (trade names Ixel, Savella, Dalcipran, Toledomin) is a serotonin–norepinephrine reuptake inhibitor (SNRI) used in the clinical treatment of fibromyalgia, major depressive disorder, and neuropathic pain. In the US, it is solely approved for the treatment of fibromyalgia, even though it is also approved for the treatment of major depressive disorder (but not fibromyalgia) in other countries (e.g. France).
==Medical uses==
Excerpted from Wikipedia’s “milnacipran” article, available under the CC BY-SA 4.0 licence.